Actively Recruiting
Fecal Microbiota Transplantation for Irritable Bowel Syndrome
Led by Guangzhou First People's Hospital · Updated on 2021-08-03
120
Participants Needed
1
Research Sites
646 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Fecal microbiota transplantation (FMT) is a strategy that infuses a fecal suspension containing a healthy donor's microbiota into a patient's gut to restore his/her intestinal microbiome. FMT has a higher cure rate than standard antibiotic treatment for recurrent Clostridium difficile infections,and shows promising results in Inflammatory bowel disease（IBD）.However, few studies have evaluated whether FMT is effective to treat Irritable bowel syndrome(IBS).The investigators propose to determine the efficiency and safety of FMT in patients with Irritable bowel syndrome.
CONDITIONS
Official Title
Fecal Microbiota Transplantation for Irritable Bowel Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Able to give written informed consent
- Men and women aged over 18 and under 75
- Diagnosed with Irritable Bowel Syndrome according to Rome IV criteria
You will not qualify if you...
- Pregnant or with less than 6 months follow-up
- Unable to give informed consent
- Having severe diseases including liver or kidney failure, cancers, intestinal diseases, inflammatory bowel disease, or Clostridium difficile infection
- Unable to undergo endoscopy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Guangzhou First People's Hospital
Guangzhou, Guangdong, China, 510180
Actively Recruiting
Research Team
H
Hongli Huang, MM
CONTACT
H
Huiting Chen, MM
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here